RBC's Top 30 Global Stock Investments for 2022
Inflation. Supply-chain issues. COVID. Investors face numerous hurdles in 2022, but RBC is confident in these 30 stocks' ability to weather the storm.


It will be tough to top the S&P 500's whopper of a performance in 2021. But investors can still look forward to "solid" if more "moderate" returns in the year ahead, says RBC Capital Markets – and perhaps even better with the right stock investments.
"The overall outlook for the next six to 12 months remains optimistic due to strong assessments for fundamentals, valuations, cash deployment and margins, balanced by more cautious views regarding fiscal policy," writes the U.S. Equity Strategy team at RBC.
True, COVID-19, inflation, labor, supply chain, pricing power and regulation remain key concerns, the strategists note. However, RBC industry analysts remain "generally confident in their companies' ability to manage through challenges, including omicron."

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
With those factors in mind, RBC Capital Markets has put together a list of their top 30 global stock investments for the year ahead. The equity strategy team's picks span the market's 11 major sectors, and in many cases overlap with Kiplinger's own 22 best stocks to buy for 2022.
Some highlights include:
- S&P Global (SPGI, $435.39). The provider of financial information, analytics and credit ratings products ranks as one of Wall Street's 12 best financial stocks. RBC is on board as well, thanks to the firm's strategic acquisition of IHS Markit (INFO). The deal, which is expected to close in the first quarter, "should accelerate [SPGI's] revenue growth profile and deliver double-digit earnings growth driven by upside to revenue and cost synergies," RBC says. (Share prices as of Jan. 10. Analysts' consensus recommendations and other data courtesy of S&P Global Market Intelligence, unless otherwise noted.)
- ConocoPhillips (COP, $81.03). The independent oil and gas exploration & production company "offers a returns-focused value proposition, a strong balance sheet, and peer-leading distributions," RBC says. The broader analyst community definitely agrees, giving COP a consensus recommendation of Buy, with high conviction, according to S&P Global Market Intelligence. Indeed, the Street is so bullish on the name that SPGI makes the list of 9 best energy stocks to buy for 2022.
- UnitedHeath Group (UNH, $465.00). The nation's largest health insurer by market value and revenue routinely ranks among analysts' top-rated Dow Jones Industrial Average stocks, and makes the list of Wall Street's 12 best healthcare stocks to buy for 2022, as well. "Despite its scale, we believe the company offers investors a strong growth profile and excellent visibility, with earnings per share increasing at a targeted 13% to 16% clip annually," notes RBC.
See the table below for RBC Capital Market's full list of 30 best global stock investments for 2022. And be sure to check out Wall Street's top stocks to buy across individual market sectors, including analysts' 12 best industrial stocks to buy for 2022, their 12 best real estate investment trusts (REITs) and their top 12 communications services stocks for the new year.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

Dan Burrows is Kiplinger's senior investing writer, having joined the publication full time in 2016.
A long-time financial journalist, Dan is a veteran of MarketWatch, CBS MoneyWatch, SmartMoney, InvestorPlace, DailyFinance and other tier 1 national publications. He has written for The Wall Street Journal, Bloomberg and Consumer Reports and his stories have appeared in the New York Daily News, the San Jose Mercury News and Investor's Business Daily, among many other outlets. As a senior writer at AOL's DailyFinance, Dan reported market news from the floor of the New York Stock Exchange.
Once upon a time – before his days as a financial reporter and assistant financial editor at legendary fashion trade paper Women's Wear Daily – Dan worked for Spy magazine, scribbled away at Time Inc. and contributed to Maxim magazine back when lad mags were a thing. He's also written for Esquire magazine's Dubious Achievements Awards.
In his current role at Kiplinger, Dan writes about markets and macroeconomics.
Dan holds a bachelor's degree from Oberlin College and a master's degree from Columbia University.
Disclosure: Dan does not trade individual stocks or securities. He is eternally long the U.S equity market, primarily through tax-advantaged accounts.
-
Do You Really Need That Wine Cellar?
Home Features Wine cellars are a popular feature in high-end houses. Will installing one in your home increase its value, or would you be better off with a cheaper solution?
-
Think a Repeal of the Estate Tax Wouldn't Affect You? Wrong
The wording of any law that repeals or otherwise changes the federal estate tax could have an impact on all of us. Here's what you need to know, courtesy of an estate planning and tax attorney.
-
Stock Market Today: Investors Look on the Bright Side
A generally good week closes on another positive note, as investors, traders and speculators look for fresh catalysts.
-
My Three-Day Rule for Investing: And If it Applies Now
Stock Market I've seen a lot in my career. Here's what I see now in the stock market.
-
Stock Market Today: Stocks Climb More Walls of Worry
Volatility is back in a normal range, and the trend for the main equity indexes remains positive despite specific and general headwinds.
-
Is It Time to Invest in Europe?
Stock Market Europe is being shaken out of its lethargy, militarily and otherwise, by Donald Trump's changes in U.S. policy. Should investors start buying?
-
Stock Market Today: Nasdaq Outperforms as Big Tech Rallies
The Dow Jones Industrial Average closed lower for a second day as Amgen and Merck fell.
-
Stock Market Today: UnitedHealth Drags on Dow After CEO Splits
UNH created headwinds for the price-weighted Dow on news that its embattled CEO, Andrew Witty, is stepping down.
-
Stock Market Today: Dow Gains 1,160 Points on U.S.-China Trade Deal
The two countries agreed to a 90-day truce that will give them time to work on more substantive trade negotiations.
-
Stock Market Today: Investors Weigh Weekend Negotiations
Investors, traders and speculators will look to Switzerland for answers about the most compelling issue confronting global markets.